Researchers Find Low Cost Drug Wipes Out Drug Resistant TB, But Worry it May Not Reach Patients in Need
NEW YORK–(ENEWSPF)–September 11, 2012 — An off-patent anti-inflammatory drug that costs around two cents for a daily dose in developing countries has been found by researchers at Weill Cornell Medical College to kill both replicating and non-replicating drug resistant tuberculosis in the laboratory — a feat few currently approved TB drugs can do, and resistance to…
